Jessica B. Flechtner

960 citations

33 papers · 692 indexed · h-index 15

Co-authors: Todd M. Gierahn Darren E. Higgins Richard Malley Paulo Gouveia Kristin Moffitt Ying‐Jie Lu Mark R. Alderson Mojca Škoberne
Topics: Immunotherapy and Immune Responses (18 papers)Cancer Immunotherapy and Biomarkers (11 papers)Herpesvirus Infections and Treatments (8 papers)
Cited by: Microbiology Virology Immunology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations: United States Netherlands

In The Last Decade

Jessica B. Flechtner

31 papers receiving 671 citations

Peers

Countries citing papers authored by Jessica B. Flechtner

Since Specialization

Citations

This map shows the geographic impact of Jessica B. Flechtner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica B. Flechtner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica B. Flechtner more than expected).

Fields of papers citing papers by Jessica B. Flechtner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica B. Flechtner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica B. Flechtner. The network helps show where Jessica B. Flechtner may publish in the future.

Co-authorship network of co-authors of Jessica B. Flechtner

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica B. Flechtner. A scholar is included among the top collaborators of Jessica B. Flechtner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica B. Flechtner. Jessica B. Flechtner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 2745: The PLANET manufacturing process reproducibly generates high-quality neoantigen-targeted peripheral T cells (NPTs) for adoptive T cell therapy in the TiTAN clinical trial 2022 ·Cancer Research ·Harshal Zope,(unknown),Manish Jain,(unknown),Louisa Dowal,James J. Foti,(unknown),Crystal Cabral,Daniel B. DeOliveira,(unknown),(unknown),Jessica B. Flechtner,Raymond D. Stapleton	0
2	485 Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors 2021 ·SHILAP Revista de lepidopterología ·Maura L. Gillison,Mark M. Awad,Przemyslaw Twardowski,Ammar Sukari,Melissa L. Johnson,Rudy P. Lackner,Mark N. Stein,Arthur P. DeCillis,Richard Hernandez,(unknown),(unknown),Mara G. Shainheit,(unknown),(unknown),(unknown),(unknown),Emily Tjon,Jessica B. Flechtner,Thomas A. Davis,Roger B. Cohen	1
3	Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors. 2021 ·Journal of Clinical Oncology ·Maura L. Gillison,Mark M. Awad,Przemyslaw Twardowski,Ammar Sukari,Melissa L. Johnson,Mark N. Stein,Richard Hernandez,(unknown),(unknown),Mara G. Shainheit,(unknown),Jessica B. Flechtner,Thomas A. Davis,Roger B. Cohen	14
4	526 Inhibigen^TM-specific responses suppress anti-tumor immunity and promote tumor growth 2020 ·Regular and Young Investigator Award Abstracts ·(unknown),Tulin Dadali,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Louisa Dowal,Jessica B. Flechtner,Alberto Visintin,Hubert Lam	1
5	Inhibigens, personal neoantigens that drive suppressive T cell responses, abrogate protection of therapeutic anti-tumor vaccines 2020 ·The Journal of Immunology ·(unknown),(unknown),(unknown),Simran Singh,(unknown),Brendan J. Classon,Jessica B. Flechtner,Hubert Lam	1
6	Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease 2019 ·Vaccine ·David I. Bernstein,Jessica B. Flechtner,Lisa K. McNeil,Thomas C. Heineman,(unknown),Sybil Tasker,Anna Wald,Seth Hetherington	27
7	A phase I trial of GEN-009, a neoantigen vaccine using ATLAS™, an autologous immune assay, to identify immunogenic and inhibitory tumour mutations 2019 ·Annals of Oncology ·P. Twardowski,Melissa L. Johnson,Mark N. Stein,Ulka N. Vaishampayan,Maura L. Gillison,Lisa K. McNeil,Louisa Dowal,Daniel B. DeOliveira,Maneesh Jain,(unknown),Richard Hernandez,Arthur P. DeCillis,Navneet Singh,Thomas A. Davis,Jessica B. Flechtner,Rachel Cohen	2
8	A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection 2018 ·Vaccine ·Lauren M. Hook,Sita Awasthi,(unknown),Jessica B. Flechtner,Deborah Long,Harvey M. Friedman	23
9	Improving Cancer Immunotherapies through Empirical Neoantigen Selection 2018 ·Trends in cancer ·(unknown),Johanna K. Kaufmann,Hubert Lam,Jessica B. Flechtner	11
10	Systematic analysis of T cell responses specific to the Epstein-Barr virus proteome using ATLAS™ 2017 ·The Journal of Immunology ·Johanna K. Kaufmann,Biao Liu,(unknown),Ning Wu,Yan Zheng,(unknown),Christine A. Kelley,(unknown),(unknown),(unknown),Jennifer Henderson,Lila Ghamsari,Kevin C. Olivieri,Jessica B. Flechtner,Wendy Broom,Emilio Flaño,Katherine Luzuriaga	1
11	Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial 2016 ·Vaccine ·Jessica B. Flechtner,Deborah Long,(unknown),(unknown),(unknown),(unknown),Jason Chan,Mojca Škoberne,(unknown),Seth Hetherington	21
12	Identification ofChlamydia trachomatisAntigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection 2016 ·The Journal of Infectious Diseases ·(unknown),Xiaojing Zheng,Catherine M. O’Connell,Harold C. Wiesenfeld,Sharon L. Hillier,Brandie D. Taylor,(unknown),Jessica B. Flechtner,Wujuan Zhong,Lauren C. Frazer,Toni Darville	41
13	Evolution of rational vaccine designs for genital herpes immunotherapy 2016 ·Current Opinion in Virology ·Johanna K. Kaufmann,Jessica B. Flechtner	8
14	Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples 2016 ·Vaccine ·(unknown),(unknown),Tamara P. Blevins,Lynda A. Morrison,(unknown),Mojca Škoberne,Robert B. Belshe,Jessica B. Flechtner,Deborah Long	6
15	Identification of novel virus-specific antigens by CD4+ and CD8+ T cells from asymptomatic HSV-2 seropositive and seronegative donors 2014 ·Virology ·Deborah Long,Mojca Škoberne,Todd M. Gierahn,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),George R. Siber,Jessica B. Flechtner	35
16	Proteins as T cell antigens: Methods for high-throughput identification 2013 ·Vaccine ·(unknown),Jessica B. Flechtner,Darren E. Higgins	19
17	High-throughput proteomic screening identifies Chlamydia trachomatis antigens that are capable of eliciting T cell and antibody responses that provide protection against vaginal challenge 2012 ·Vaccine ·Michele D. Picard,(unknown),Todd M. Gierahn,Darren E. Higgins,Jessica B. Flechtner	25
18	Distinct Effects on Diversifying Selection by Two Mechanisms of Immunity against Streptococcus pneumoniae 2012 ·PLoS Pathogens ·Yuan Li,Todd M. Gierahn,Claudette M. Thompson,Krzysztof Trzciński,Christopher B. Ford,Nicholas J. Croucher,Paulo Gouveia,Jessica B. Flechtner,Richard Malley,Marc Lipsitch	38
19	TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization 2011 ·Cell Host & Microbe ·Kristin Moffitt,Todd M. Gierahn,Ying‐Jie Lu,Paulo Gouveia,Mark R. Alderson,Jessica B. Flechtner,Darren E. Higgins,Richard Malley	152
20	High-Affinity Interactions between Peptides and Heat Shock Protein 70 Augment CD8+ T Lymphocyte Immune Responses 2006 ·The Journal of Immunology ·Jessica B. Flechtner,(unknown),Sunil Mehta,Paul Slusarewicz,Alexis Leonard,Brian H. Barber,Daniel L. Levey,Sofija Andjelić	51

About Jessica B. Flechtner

Jessica B. Flechtner is a scholar working on Immunology, Microbiology and Virology, having authored 33 papers that have together received 692 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Herpesvirus Infections and Treatments (8 papers). The work is most often cited by research in Microbiology (175 citations), Virology (66 citations) and Immunology (289 citations). Jessica B. Flechtner has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Todd M. Gierahn, Darren E. Higgins, Richard Malley, Paulo Gouveia, Kristin Moffitt, Ying‐Jie Lu, Mark R. Alderson, Mojca Škoberne, Deborah Long and David I. Bernstein. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact